SCHEMBL20819191

SCHEMBL20819191

O=C(O)CC(C(=O)NCCc1cccc(C(F)(F)F)c1)N1C(=O)C(N2C(=O)OC[C@@H]2c2ccccc2)C1C=Cc1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20819219 1.00 AVPR1A (0.75) AVPR1A
SCHEMBL42820 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL28464247 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL42369 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL28466518 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL22370915 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL22370913 0.93 AVPR1A (0.86) AVPR1A
SCHEMBL17114119 0.92 AVPR1A (0.71) AVPR1A
SCHEMBL45462 0.88 AVPR1A (0.89) AVPR1A
SCHEMBL20819214 0.88 AVPR1A (0.89) AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681871-A1 COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY Azevan Pharmaceuticals, Inc. (US) 2020-07-22 EP disclosed
WO-2019055913-A1 COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY AZEVAN PHARMACEUTICALS, INC. (US) 2019-03-21 WO disclosed